HKSE - Delayed Quote HKD

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)

49.500

-0.500

(-1.00%)

At close: January 28 at 11:50:25 AM GMT+8

Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow

MORRISVILLE, N.C., November 12, 2024--To facilitate large-scale production of peptide drugs, Asymchem, a leading global pharmaceutical CDMO, has achieved fully automated manufacturing.

Business Wire 2 months ago

ASLTY
Building a World-Class Synthetic Biology Lab: Asymchem’s Self-Developed STAR System Empowers Protein Design

MORRISVILLE, N.C., November 06, 2024--Asymchem, a leading global CDMO, has created an artificial intelligence (AI) platform to address key challenges in protein design.

Business Wire 2 months ago

ASLTY
Advanced Manufacturing, Global Reach, and Streamlined Services — Asymchem Impresses at CPHI Milan 2024

MILAN, October 30, 2024--Asymchem, a global leader in contract development and manufacturing organization (CDMO) services, made a strong impact at CPHI Milan 2024.

Business Wire 2 months ago

ASLTY
Asymchem Inaugurates Its First European Small Molecule Development and API Pilot Plant Manufacturing Site at Discovery Park in Sandwich, Kent, UK

TEDA TIANJIN, China, August 02, 2024--Asymchem announced it has inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K.

Business Wire 5 months ago

6821.HK
-1.00%
Asymchem Appoints Dr. Cheng Yi Chen as CTO of Small-Molecule Sector

TEDA TIANJIN, China, June 26, 2024--Dr. Cheng Yi Chen joined Asymchem as CTO of the Small-Molecule Sector to provide technical support to the group’s chemical small molecule sales.

Business Wire 7 months ago

6821.HK
-1.00%
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development

PARIS, May 29, 2024--Asymchem announces the appointment of Franck Mevellec as senior director, business development.

Business Wire 7 months ago

6821.HK
-1.00%
Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities

TEDA TIANJIN, China, May 21, 2024--Asymchem establishes their first manufacturing facility in Europe with the acquisition of a former Pfizer small molecule API pilot plant in Sandwich.

Business Wire 8 months ago

6821.HK
-1.00%
002821.SZ

Performance Overview

Return	6821.HK	SSE Composite Index
YTD	-5.17%	-4.60%
1-Year	-22.15%	+11.70%
3-Year	-72.74%	-4.23%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)

Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow

Building a World-Class Synthetic Biology Lab: Asymchem’s Self-Developed STAR System Empowers Protein Design

Advanced Manufacturing, Global Reach, and Streamlined Services — Asymchem Impresses at CPHI Milan 2024

Asymchem Inaugurates Its First European Small Molecule Development and API Pilot Plant Manufacturing Site at Discovery Park in Sandwich, Kent, UK

Asymchem Appoints Dr. Cheng Yi Chen as CTO of Small-Molecule Sector

Asymchem Welcomes Franck Mevellec as Senior Director, Business Development

Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities

Performance Overview